Latest filing published 21 Nov 2011 for CURAXIS PHARMACEUTICAL Corp, €3,474.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stephen J. Leary: trading record in brief
Stephen J. Leary discloses dealings in CURAXIS PHARMACEUTICAL Corp to SEC (Form 4). In total, 6 filings cover trades dated from 15 August 2011 to 19 January 2012.
Purchases make up the whole of the open-market record (3 purchases, €11k). No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants.
The record was last updated on 24 January 2012 with a share grant (€6,218) in CURAXIS PHARMACEUTICAL Corp. The latest purchase dates back some time: it was published 5,513 days ago, on 5 October 2011. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen J. Leary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 55,000 shares@ US$0.0849Common StockSEC:0001354488-11-004626:0
- 39,229 shares@ US$0.0849Common StockSEC:0001354488-11-004626:1
- 50,000 shares0Common StockSEC:0001354488-11-003686:0Canonical exit: 1 Jan 2012 (T+90)
- 100,000 shares@ US$0.05Common StockSEC:0001354488-11-003493:0Canonical exit: 15 Dec 2011 (T+90)
- 200,000 shares@ US$0.05Common StockSEC:0001354488-11-002805:0Canonical exit: 13 Nov 2011 (T+90)
5 of 5 declarations